CN1160128C - 含有丙二醇和异丙基链烷酸酯的抗病毒制剂 - Google Patents

含有丙二醇和异丙基链烷酸酯的抗病毒制剂 Download PDF

Info

Publication number
CN1160128C
CN1160128C CNB998133825A CN99813382A CN1160128C CN 1160128 C CN1160128 C CN 1160128C CN B998133825 A CNB998133825 A CN B998133825A CN 99813382 A CN99813382 A CN 99813382A CN 1160128 C CN1160128 C CN 1160128C
Authority
CN
China
Prior art keywords
weight
composition
propylene glycol
antiviral
hydrocortisone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB998133825A
Other languages
English (en)
Chinese (zh)
Other versions
CN1326364A (zh
Inventor
G
G·莱卡雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivir AB
Original Assignee
Medivir AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1160128(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medivir AB filed Critical Medivir AB
Publication of CN1326364A publication Critical patent/CN1326364A/zh
Application granted granted Critical
Publication of CN1160128C publication Critical patent/CN1160128C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNB998133825A 1998-11-18 1999-11-12 含有丙二醇和异丙基链烷酸酯的抗病毒制剂 Expired - Lifetime CN1160128C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803929A SE9803929D0 (sv) 1998-11-18 1998-11-18 Antiviral formulation
SE98039290 1998-11-18

Publications (2)

Publication Number Publication Date
CN1326364A CN1326364A (zh) 2001-12-12
CN1160128C true CN1160128C (zh) 2004-08-04

Family

ID=20413320

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998133825A Expired - Lifetime CN1160128C (zh) 1998-11-18 1999-11-12 含有丙二醇和异丙基链烷酸酯的抗病毒制剂

Country Status (21)

Country Link
EP (1) EP1131104B1 (enExample)
JP (2) JP2002529520A (enExample)
KR (1) KR100608963B1 (enExample)
CN (1) CN1160128C (enExample)
AR (1) AR023705A1 (enExample)
AT (1) ATE288283T1 (enExample)
AU (1) AU772435B2 (enExample)
CA (1) CA2351463C (enExample)
DE (1) DE69923584T2 (enExample)
DK (1) DK1131104T3 (enExample)
EG (1) EG23853A (enExample)
ES (1) ES2233104T3 (enExample)
HK (1) HK1042440B (enExample)
IL (2) IL142702A0 (enExample)
MY (1) MY122397A (enExample)
NZ (1) NZ511832A (enExample)
PT (1) PT1131104E (enExample)
SE (1) SE9803929D0 (enExample)
TW (1) TW589191B (enExample)
WO (1) WO2000029027A1 (enExample)
ZA (1) ZA200103335B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100956369B1 (ko) * 2001-11-19 2010-05-10 메디진 아게 바이러스성 피부 질환 및 종양 질환 치료용 약제
ZA200602544B (en) 2003-10-09 2007-06-27 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
ES2955089T3 (es) * 2018-08-17 2023-11-28 Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi Composición tópica estable en fase que comprende aciclovir e hidrocortisona

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers

Also Published As

Publication number Publication date
HK1042440A1 (en) 2002-08-16
EG23853A (en) 2007-11-06
AU1436400A (en) 2000-06-05
AU772435B2 (en) 2004-04-29
TW589191B (en) 2004-06-01
CN1326364A (zh) 2001-12-12
DK1131104T3 (da) 2005-03-14
ES2233104T3 (es) 2005-06-01
IL142702A (en) 2006-07-05
HK1042440B (zh) 2005-04-29
EP1131104B1 (en) 2005-02-02
ZA200103335B (en) 2002-07-24
MY122397A (en) 2006-04-29
NZ511832A (en) 2003-09-26
ATE288283T1 (de) 2005-02-15
CA2351463C (en) 2009-10-13
DE69923584T2 (de) 2006-03-23
JP2002529520A (ja) 2002-09-10
IL142702A0 (en) 2002-03-10
KR20010075720A (ko) 2001-08-09
PT1131104E (pt) 2005-03-31
EP1131104A1 (en) 2001-09-12
WO2000029027A1 (en) 2000-05-25
JP5420583B2 (ja) 2014-02-19
SE9803929D0 (sv) 1998-11-18
CA2351463A1 (en) 2000-05-25
AR023705A1 (es) 2002-09-04
JP2011157392A (ja) 2011-08-18
KR100608963B1 (ko) 2006-08-09
DE69923584D1 (de) 2005-03-10

Similar Documents

Publication Publication Date Title
CN1172674C (zh) 促进渗透和减少刺激的系统
CN1171736A (zh) 基质型贴剂
CN1111513A (zh) 含联苯苄唑的杀真菌组合物
CN1239427A (zh) Mupirocin在制备用于治疗与病原生物体鼻咽建群有关的细菌感染的药物中的应用
US20170020882A1 (en) Antiviral formulation
US7223387B2 (en) Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
CN1160128C (zh) 含有丙二醇和异丙基链烷酸酯的抗病毒制剂
CN1583175A (zh) 具有皮肤靶向性的药物组合物及其制备方法和用途
CN1056058C (zh) 药物制剂的制备方法
CN1191834C (zh) 含有二甲聚硅氧烷的阿昔洛韦组合物
CN1039284C (zh) 治疗疼痛和增强疼痛解除作用的组合物
CN1042298C (zh) 含鬼臼毒的乳膏形式的药物组合物的制备方法
MXPA01005020A (en) Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
RU2225200C1 (ru) Фармацевтический состав с противогерпесной активностью и способ лечения вирусной инфекции
CN1161651A (zh) 透皮给药制剂
HK1023723A (en) Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
HK1056116B (en) Sucrose ester c-20 to c-28 alcohol formulation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1042440

Country of ref document: HK

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20040804